New Aspects in the Diagnosis and Treatment of Hodgkin's Disease
General Material Designation
[Book]
First Statement of Responsibility
edited by Volker Diehl, Michael Pfreundschuh, Markus Loeffler.
.PUBLICATION, DISTRIBUTION, ETC
Place of Publication, Distribution, etc.
Berlin, Heidelberg
Name of Publisher, Distributor, etc.
Springer Berlin Heidelberg
Date of Publication, Distribution, etc.
1989
PHYSICAL DESCRIPTION
Specific Material Designation and Extent of Item
(xiv, 283 pages 71 illustrations)
SERIES
Series Title
Recent results in cancer research, 117.
CONTENTS NOTE
Text of Note
Pathology and Cell Biology of Hodgkin's Disease --; Pathology of Hodgkin's Disease: Anything New? --; Immunology of Hodgkin and Reed-Sternberg Cells --; DNA Gene Rearrangement Studies in Hodgkin's Disease and Related Lymphomas: A Contribution to Their Cellular Origin. --; Genetics of Hodgkin's Lymphoma --; Hodgkin's Disease Derived Cell Lines --; Biology of Hodgkin Cell Lines --; Phenotypic and Genotypic Analysis of Two Cell Lines Derived from Hodgkin's Disease Tissue Biopsies --; The Typical Reed-Sternberg Phenotype and I g Gene Rearrangements of Hodgkin's Disease Derived Cell Line ZO Indicating a B-Cell Origin --; Characterization of Hodgkin's Disease Derived Cell Line HDLM-2 --; A New Hypothesis on the Cellular Origin of Reed-Sternberg and Hodgkin Cells Based on the Immunological and Molecular Genetic Analysis of the KM-H2 Line --; A Marker and Putative Pathoantigen of Hodgkin's Cells --; Development in Diagnostic Procedures --; Radiolabeled Monoclonal Antibodies Against Reed-Sternberg Cells for in Vivo Imaging of Hodgkin's Disease by Immunoscintigraphy --; Diagnostic Strategies and Staging Procedures for Hodgkin's Lymphoma: Bone Marrow Scintigraphy and Magnetic Resonance Imaging --; Therapeutic Strategies --; Overviews --; Radiotherapy Trials in Hodgkin's Disease --; Current Status of Chemotherapy for Hodgkin's Disease --; Report on Recent and Current Clinical Trials --; Risk Factor Adapted Treatment of Hodgkin's Lymphoma: Strategies and Perspectives --; Reduced Combined Radiotherapy and Chemotherapy for Hodgkin's Disease --; Risk-Adapted Treatment Approach --; Hodgkin's Disease: The Milan Cancer Institute Experience with MOPP and ABVD --; EORTC Lymphoma Cooperative Group Studies in Clinical Stage I-II Hodgkin's Disease --; 1963 1987 --; Current Stanford Clinical Trials for Hodgkin's Disease --; Results and Prognostic Factors Following Optimal Treatment in Advanced Hodgkin's Disease --; Two Cycles of MOPP and Definitive Radiotherapy for Stage IIIA and III B Hodgkin's Disease --; Risk Factor Adapted Treatment of Hodgkin's Lymphoma in Childhood: Strategies and Results of Three Consecutive Multicenter Studies in the Federal Republic of Germany --; Hodgkin's Disease in Children: Adaptation of Treatment to Risk Factors --; Role of Bone Marrow Transplantation in the Treatment of Hodgkin's Lymphoma --; Conventional Salvage Therapy for Hodgkin's Lymphoma --; High-Dose Combination Chemotherapy with Cyclophosphamide, Carmustine, Etoposide, and Autologous Bone Marrow Transplantation in 60 Patients with Relapsed Hodgkin's Disease: The M.D. Anderson Experience --; Treatment of Resistant Hodgkin's Lymphoma with Bone Marrow Transplantation in Italy --; Preliminary Results of Autologous Bone Marrow Transplantation in the Management of Resistant Hodgkin's Disease: Experience of the Bloomsbury Transplant Group at University College, London --; Bone Marrow Transplantation in the Treatment of Hodgkin's Lymphoma: Problems, Remaining Challenges, and Future Prospects --; Acute and Late Side Effects of Treatment --; Quality of Life During and After Treatment of Hodgkin's Disease --; Risk of Secondary Acute Leukemia and Preleukemia After Hodgkin's Disease: The Institut Gustave-Roussy Experience.
SUMMARY OR ABSTRACT
Text of Note
This work contains recent results of basic and clinical studies in Hodgkin's disease up to early 1988. It deals with tumor immunological, genetical and molecular biological findings obtained from Hodgkin's derived cell lines and biopsies of lymphomas in Hodgkin's disease. New aspects concerning the histopathology of Hodgkin's disease are also described. In the clinical section recent developments in diagnosis such as immunoscintigraphy with monoclonal antibodies and bone marrow scintigraphy are dealt with, as are new therapeutic approaches that take into account the relevance of risk factor analysis for therapeutic strategies. Finally, new therapeutic avenues such as bone marrow transplantation are covered in detail. The best known researchers in the field present their latest data in this volume, thus assuring that all relevant aspects of Hodgkin's disease are covered.
TOPICAL NAME USED AS SUBJECT
Allergy.
Immunology.
Medicine.
LIBRARY OF CONGRESS CLASSIFICATION
Class number
RC261
Book number
.
E358
1989
PERSONAL NAME - PRIMARY RESPONSIBILITY
edited by Volker Diehl, Michael Pfreundschuh, Markus Loeffler.